Tavio Capital LLC Q2 2020 vs. Q3 2020 13F Holdings Comparison

As a professional blog writer, staying updated on financial news and trends is crucial. One of the essential sources of information for investors is the quarterly filings of 13F Holdings. These forms provide insight into the changes that institutional investors have made to their portfolios. In this article, we will examine the Q2 2020 vs. Q3 2020 filings of Tavio Capital LLC and see the changes they made to their holdings.

Tavio Capital LLC, a New York-based institutional investor, manages over $2 billion in assets and primarily invests in the healthcare sector. Looking at their Q2 2020 holdings, we see that Molina Healthcare Inc (MOH), McKesson Corp (MCK), and Zimmer Biomet Holdings Inc (ZBH) were their three largest positions, with each stock accounting for over 10% of their portfolio. However, in the Q3 2020 filing, we see that Tavio Capital has completely exited all three positions.

Molina Healthcare Inc (MOH), an American healthcare company that provides managed care services under the Medicaid and Medicare programs, accounted for 7.67% of Tavio Capital's portfolio in Q2 2020. However, in Q3 2020, they sold all their shares, indicating that they no longer believe in the company's growth potential.

Similarly, McKesson Corp (MCK), a global healthcare supply chain management company, and Zimmer Biomet Holdings Inc (ZBH), a worldwide leader in musculoskeletal healthcare, were the second and third-largest positions in Q2 2020, respectively. Tavio Capital sold all their shares in both companies in Q3 2020, indicating that they no longer see a future in these stocks.

In Q2 2020, Cigna Corp New (CI), Baxter Intl Inc (BAX), Patterson Cos Inc (PDCO), and Exact Sciences Corp (EXAS) accounted for over 10% of Tavio Capital's portfolio. However, in Q3 2020, Tavio Capital has exited all these positions, indicating a significant change in their investment strategy.

Finally, Centene Corp Del (CNC) was an important position for Tavio Capital in Q2 2020, accounting for 5.54% of their portfolio. However, in Q3 2020, they sold all their shares in the company, indicating a lack of confidence in its growth prospects.

In conclusion, Tavio Capital LLC has made significant changes to their portfolio between Q2 2020 and Q3 2020, completely exiting their largest positions in MOH, MCK, and ZBH, and all other holdings. As the healthcare sector continues to evolve rapidly, it will be interesting to see where Tavio Capital LLC decides to allocate their funds in the coming quarters.